<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the dose-dependent effect of free fatty acid (FFA) on the hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake (HGU), we determined hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> fluxes by a dual tracer technique during the basal state and euglycemic hyperinsulinemic clamp combined with a portal <z:chebi fb="105" ids="17234">glucose</z:chebi> load in three groups of rats given saline (saline), low-dose <z:chebi fb="23" ids="18059">lipid</z:chebi> (<z:chebi fb="23" ids="18059">lipid</z:chebi>-L), or high-dose <z:chebi fb="23" ids="18059">lipid</z:chebi> infusion (<z:chebi fb="23" ids="18059">lipid</z:chebi>-H) </plain></SENT>
<SENT sid="1" pm="."><plain>In the basal state, <z:chebi fb="23" ids="18059">lipid</z:chebi> infusion dose-dependently increased plasma FFA (saline, 400 +/- 50; <z:chebi fb="23" ids="18059">lipid</z:chebi>-L, 550 +/- 30; <z:chebi fb="23" ids="18059">lipid</z:chebi>-H, 1700 +/- 270 micromol l(-1); mean +/- S.E) </plain></SENT>
<SENT sid="2" pm="."><plain>Endogenous <z:chebi fb="105" ids="17234">glucose</z:chebi> production (EGP) in <z:chebi fb="23" ids="18059">lipid</z:chebi>-H was 63.5 +/- 5.5 micromol kg(-1) min(-1) and significantly higher than in the saline and <z:chebi fb="23" ids="18059">lipid</z:chebi>-L (40.2 +/- 2.9, 47.6 +/- 3.1 micromol kg(-1) min(-1), respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>During euglycemic hyperinsulinemic clamp, plasma FFA decreased to 130 +/- 30 micromol l(-1) in saline, but remained at basal levels in <z:chebi fb="23" ids="18059">lipid</z:chebi>-L and <z:chebi fb="23" ids="18059">lipid</z:chebi>-H (470 +/- 30 and 1110 +/- 180 micromol l(-1), respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>Insulin-suppressed EGP was complete in saline and <z:chebi fb="23" ids="18059">lipid</z:chebi>-L, but impaired in <z:chebi fb="23" ids="18059">lipid</z:chebi>-H (38.0 +/- 6.4 micromol kg(-1) min(-1)) </plain></SENT>
<SENT sid="5" pm="."><plain>Elevated FFA dose-dependently reduced HGU (saline, 12.2 +/- 0.9; <z:chebi fb="23" ids="18059">lipid</z:chebi>-L, 8.6 +/- 0.6; <z:chebi fb="23" ids="18059">lipid</z:chebi>-H, 4.7 +/- 1.4 micromol kg(-1) min(-1)) </plain></SENT>
<SENT sid="6" pm="."><plain>In conclusion, acutely elevated FFA impairs HGU as well as insulin-mediated suppression of EGP during hyperinsulinemic clamp with portal <z:chebi fb="105" ids="17234">glucose</z:chebi> loading </plain></SENT>
<SENT sid="7" pm="."><plain>Impaired hepatic <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake associated with elevated FFA may contribute to the development of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> in <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>